How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink
After years of layoffs, cash burn and political attacks on its core technology, Moderna’s melanoma vaccine data notched the biotech company a much-needed win.
Connecting Global Economies
Flash News
Anna Faris Challenges Her, Chris Pratt’s Son Jack on Religious Beliefs
‘I’m on the ballot’: Trump lends a hand to struggling Darline Graham
Ravens WR Rashod Bateman faces family violence charge after allegedly breaking windshield
How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink
Why is Trump threatening to bomb Oman, the Iran mediator trying to clear Hormuz?
Husted defends energy policy as GOP warns data centers put Ohio seat at risk
How Woody Harrelson Learned He, Matthew McConaughey May Be Related
Messi fined by MLS for striking opponent; Cavan Sullivan’s red card rescinded
AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
In Focus | As natural disasters rage, does China’s ‘top-down’ climate model provide a way forward?
Saturday, August 22, 2026
